Washington University School of Medicine, Siteman Cancer Center is a clinical research site located in St Louis, Missouri, United States 63110.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Washington University School of Medicine, Siteman Cancer Center has participated in 11 clinical trials with 4 currently active.
Therapeutic areas: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Sponsors: Pfizer, Bristol-Myers Squibb, Compass Therapeutics.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Washington University School of Medicine, Siteman Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Washington University School of Medicine, Siteman Cancer Center has 11 clinical trials on record, with 4 currently active. Their work covers Acute Myeloid Leukemia, Myelodysplastic Syndrome, Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Yes — Washington University School of Medicine, Siteman Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.